These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6609359)

  • 1. Differential effects of the mottled yellow and pseudoagouti phenotypes on immunocompetence in Avy/a mice.
    Roberts DW; Wolff GL; Campbell WL
    Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2152-6. PubMed ID: 6609359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic glutathione S-transferase activity in mice: effects of Avy/-genotype, obesity, lindane treatment, and sex.
    Wolff GL; Suber RL
    Proc Soc Exp Biol Med; 1986 Apr; 181(4):535-41. PubMed ID: 2419915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple levels of response in carcinogenicity bioassays: regulational variation among viable yellow (Avy/-) mice.
    Wolff GL
    J Exp Anim Sci; 1993 Sep; 35(5-6):221-31. PubMed ID: 8218437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumorigenic responses to lindane in mice: potentiation by a dominant mutation.
    Wolff GL; Roberts DW; Morrissey RL; Greenman DL; Allen RR; Campbell WL; Bergman H; Nesnow S; Frith CH
    Carcinogenesis; 1987 Dec; 8(12):1889-97. PubMed ID: 2445499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of age and obesity on the metabolism of lindane by black a/a, yellow Avy/a, and pseudoagouti Avy/a phenotypes of (YS x VY) F1 hybrid mice.
    Chadwick RW; Copeland MF; Wolff GL; Cooke N; Whitehouse DA; Mole ML
    J Toxicol Environ Health; 1985; 16(6):771-96. PubMed ID: 2419580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal determination of obesity, tumor susceptibility, and coat color pattern in viable yellow (Avy/a) mice. The yellow mouse syndrome.
    Wolff GL; Roberts DW; Galbraith DB
    J Hered; 1986; 77(3):151-8. PubMed ID: 3734404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of maternal phenotype on metabolic differentiation of agouti locus mutants in the mouse.
    Wolff GL
    Genetics; 1978 Mar; 88(3):529-39. PubMed ID: 640377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saturation of lindane metabolism in chronically treated (YS x VY) F1 hybrid mice.
    Chadwick RW; Copeland MF; Wolff GL; Stead AG; Mole ML; Whitehouse DA
    J Toxicol Environ Health; 1987; 20(4):411-34. PubMed ID: 2435921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response effects of ectopic agouti protein on iron overload and age-associated aspects of the Avy/a obese mouse phenome.
    Wolff GL; Whittaker P
    Peptides; 2005 Oct; 26(10):1697-711. PubMed ID: 15982784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice.
    Wolff GL; Kodell RL; Moore SR; Cooney CA
    FASEB J; 1998 Aug; 12(11):949-57. PubMed ID: 9707167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agouti signaling protein stimulates cell division in "viable yellow" (A(vy)/a) mouse liver.
    Wolff GL; Stanley JS; Ferguson ME; Simpson PM; Ronis MJ; Badger TM
    Exp Biol Med (Maywood); 2007 Nov; 232(10):1326-9. PubMed ID: 17959845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenome modulated xenobiotic detoxification pathways control DMBA-induced breast cancer in agouti A
    Mazambani S; Morris M; Cheriyath V
    Epigenetics; 2019 Jul; 14(7):708-720. PubMed ID: 31070092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential spontaneous transformation in vitro of newly established mouse fibroblast lines carrying or lacking the viable yellow mutation (Avy) of the mouse agouti locus.
    Hsiao WL; Wolff GL; North BM; Ollmann MM; Barsh GS; Fan H
    Mol Carcinog; 1996 Jan; 15(1):70-80. PubMed ID: 8561869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phaeomelanin synthesis and obesity in mice. Interaction of the viable yellow (Avy) and sombre (eso) mutations.
    Wolff GL; Galbraith DB; Domon OE; Row JM
    J Hered; 1978; 69(5):295-8. PubMed ID: 744871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-specific locomotor response to nicotine in yellow and mottled yellow A(vy)/a mice.
    Dingman MA; Gyekis JP; Whetzel CA; Klein LC; Vandenbergh DJ
    BMC Res Notes; 2013 Dec; 6():497. PubMed ID: 24289264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential responses of yellow Avy/A and agouti A/a (BALB/c X VY) F1 hybrid mice to the same diets: glucose tolerance, weight gain, and adipocyte cellularity.
    Frigeri LG; Wolff GL; Teguh C
    Int J Obes; 1988; 12(4):305-20. PubMed ID: 3058616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Models for assessing the effect of toxicants on immunocompetence in mice. II. Effect of cyclophosphamide on the antibody responses to type III pneumococcal polysaccharide and tetanus toxoid in BALB/c female mice.
    Speirs RS; Benson RW; Knowles BJ; Roberts D
    J Environ Pathol Toxicol; 1978; 1(6):791-812. PubMed ID: 32218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soy protein isolate reduces hepatosteatosis in yellow Avy/a mice without altering coat color phenotype.
    Badger TM; Ronis MJ; Wolff G; Stanley S; Ferguson M; Shankar K; Simpson P; Jo CH
    Exp Biol Med (Maywood); 2008 Oct; 233(10):1242-54. PubMed ID: 18791133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of immunocompetence measures in a White Leghorn chicken line.
    Cheng S; Lamont SJ
    Poult Sci; 1988 Jul; 67(7):989-95. PubMed ID: 3265514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro humoral immunity in surgical patients: antibody response to pneumococcal polysaccharide.
    Nohr CW; Latter DA; Meakins JL; Christou NV
    Surgery; 1986 Aug; 100(2):229-38. PubMed ID: 3488597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.